ZC3H12B, a new active member of the ZC3H12 family.

ZC3H12B is the most enigmatic member of the ZC3H12 protein family. The founding member of this family, Regnase-1/MCPIP1/ZC3H12A, is a well-known modulator of inflammation and is involved in the degradation of inflammatory mRNAs. In this study, for the first time, we characterized the properties of the ZC3H12B protein. We show that the biological role of ZC3H12B depends on an intact NYN/PIN RNase domain. Using RNA immunoprecipitation,experiments utilizing actinomycin D and ELISA, we show that ZC3H12B binds endogenous proinflammatory interleukin-6 (IL-6) mRNA in vivo, regulates its turnover and results in reduced production of IL-6 protein upon proinflammattory stimulation with IL 1β. We verified that regulation of IL-6 mRNA stability occurs via interaction of ZC3H12B with the stem-loop structure present in the IL-6 3'UTR. The IL-6 transcript is not the only target of ZC3H12B. ZC3H12B also interacts with other known substrates of Regnase 1 and ZC3H12D, such as the 3'UTRs of IER3 and Regnase-1, and binds IER3 mRNA in vivo. Using immunofluorescence, we examined the localization of ZC3H12B within the cell. The obtained results are consistent with the proposed function of ZC3H12B. ZC3H12B forms small, granule-like structures in the cytoplasm that are characteristic of proteins involved in mRNA turnover control. The overexpression of ZC3H12B inhibits proliferation by stalling the cell cycle in the G2 phase. This effect of ZC3H12B is also NYN/PIN dependent. The analysis of ZC3H12B mRNA level reveals its highest expression in the human brain and the neuroblastoma cell line SH SY5Y although the factors regulating its expression remain elusive. Downregulation of ZC3H12B in SH-SY5Y cells by specific shRNAs results in upregulation of ZC3H12B-target mRNAs.